News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
ESTRO Announces Target Volume Determination Course in Bucharest
ESTRO/X
May 13, 2025, 09:26

ESTRO Announces Target Volume Determination Course in Bucharest

European SocieTy for Radiotherapy and Oncology – ESTRO shared on X:

“Join the Target Volume Determination course in Bucharest

25–27 June 2025
Perfect for trainees and professionals in Radiation Oncology, Medical Physics and more.”

More posts by ESTRO see on OncoDaily.

cancer ESTRO OncoDaily Oncology radiation oncology
Special Coverage
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski
Oncolibrary
Jun 26, 2025, 14:50
What Is a Chemotherapy Port? Uses, Benefits and Complications
OncoDaily Pulse
Jun 26, 2025, 14:45
Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night
Blog
Jun 26, 2025, 14:20
Sendurai Mani: Gratitude and Great Science at our Lab Retreat
Oncolibrary
Jun 26, 2025, 14:14
MASCC 2025 Highlights: MuReva OM Dramatically Reduces Severe Oral Mucositis in HNC
Oncolibrary
Jun 26, 2025, 14:12
MASCC 2025 Highlights: Key Toxicity Findings in ADC-Treated Cancer Patients
Blog
Jun 26, 2025, 14:05
Mieke Van Hemelrijck Joined EORTC Board and General Assembly Meetings 2025 in Brussels
Blog
Jun 26, 2025, 13:52
Tracey O’Brien Shared Rare Cancer Patient Hamish’s Story on 2025 Rare Cancers Awareness Day
Blog
Jun 26, 2025, 13:31
Yan Leyfman: Ejaculation Frequency Linked to Lower Prostate Cancer Risk
Insight
Jun 26, 2025, 13:15
Celebrating Innovation, Impact and Empathy in Cancer Care - 2025 CancerX Accelerator Showcase Honored 3 Standout Startups
Blog
Jun 26, 2025, 12:40
Sami Mansfield: How I Help Bridge the Gap in Patient-centered Care - 3 Actionable Strategies for Oncology Teams
Oncolibrary
Jun 26, 2025, 12:32
MASCC 2025: Sarcopenia and CT Fat Metrics Show No Survival Impact in NSCLC